Shreya Mehta

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors

Shreya Mehta, Philip R. de Reuver, Preetjote Gill et al. · Medicine · 2015 · 71 citations · Full text

Medicine, Endocrinology, Oncology +17

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy

Sumit Sahni, Christopher B. Nahm, Christoph Krisp et al. · Frontiers in Oncology · 2020 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +17

Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors

Philip R. de Reuver, Shreya Mehta, Preetjote Gill et al. · Journal of the American College of Surgeons · 2015 · 30 citations

Medicine, Immunology, Oncology +13

Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma

Nadya Rykina-Tameeva, Christopher B. Nahm, Shreya Mehta et al. · HPB · 2020 · 23 citations

Medicine, Cancer Biology, Oncology +12